Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study
Di Carlo, C.; Sansone, A.; De Rosa, N.; Gargano, V.; Tommaselli, G.A.; Nappi, C.; Bifulco, G.
Gynecological Endocrinology the Official Journal of the International Society of Gynecological Endocrinology 30(1): 53-56
2014
ISSN/ISBN: 1473-0766 PMID: 24131079 DOI: 10.3109/09513590.2013.848851Document Number: 576502
The aim of the study was to determine the impact of etonogestrel (ENG)-implant used for contraceptive purpose on Quality of life (QoL) and on sexual function (FSF) of healthy Italian women. The Female Sexual Function Index (FSFI) questionnaire and the Short Form-36 (SF-36) validated questionnaire were administered at baseline, 3 and 6 months after insertion of Nexplanon. The implant seems to have a positive impact on QoL after the first three months of therapy. Users showed an improved general health status and physical role status. The implant did not show negative effects on libido and on sexual function. In the first three months of treatment, users experienced a temporary reduction of vitality, mental health, social functioning and emotional role functioning, which seem to disappear after six months of therapy.